EntreMed
EntreMed receives composition-of-matter patent for 2ME2
Published in Pharma Law Weekly, September 12th, 2006
2ME2 is currently in Phase 1 and 2 clinical trials for cancer (Panzem NCD), as well as in preclinical development for rheumatoid arthritis. This patent further strengthens EntreMed's intellectual property protection for 2ME2 to include highly purified compositions and extends the patent life for 2ME2 to 2022.
Patent No. 7,087,592 entitled "Compositions Comprising Purified 2-Methoxyestradiol...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-09-12)
More Articles from Pharma Law Weekly
- Ariad Pharmaceuticals
Ariad gets patent covering mTOR inhibitors, treatment methods in cancer and restenosis - Arrowhead Research
Arrowhead announces issuance of patent on subsidiary's key technology - Columbia University, U.S.
Recent findings in colon cancer described by researchers from the United States and Taiwan - Costa Brava
Costa Brava Partnership III L.P. files suit against Bradley Pharmaceuticals, Inc. - Food and Drug Administration, U.S.
U.S. FDA warns three pharmacies to stop mass-producing unapproved inhalation drugs - Global HIV Prevention Working Group
New HIV prevention methods in sight, but major hurdles remain, say experts - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
